{"id":4274,"date":"2023-05-24T13:42:52","date_gmt":"2023-05-24T05:42:52","guid":{"rendered":"https:\/\/regask.com\/?p=4274"},"modified":"2024-10-17T00:16:15","modified_gmt":"2024-10-16T16:16:15","slug":"webinaire-sur-les-essais-cliniques-decentralises-de-la-fda","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/fda-decentralized-clinical-trials-webinar\/","title":{"rendered":"La FDA am\u00e9ricaine annonce un webinaire pour discuter des essais d\u00e9centralis\u00e9s\u2026"},"content":{"rendered":"<div>\n<div><a href=\"https:\/\/www.fda.gov\/\" target=\"_blank\" rel=\"noopener\">FDA des \u00c9tats-Unis<\/a> La FDA a r\u00e9cemment publi\u00e9 le projet de lignes directrices sur les essais cliniques d\u00e9centralis\u00e9s et a \u00e9galement programm\u00e9 un webinaire pour discuter de ce projet de lignes directrices. Le projet de lignes directrices porte sur les essais cliniques d\u00e9centralis\u00e9s pour les m\u00e9dicaments, les produits biologiques et les dispositifs m\u00e9dicaux Projet de lignes directrices \u00e0 l&#039;intention de l&#039;industrie, des chercheurs et des autres parties prenantes (fda.gov)<\/div>\n<div><\/div>\n<div><strong>D\u00e9tails du webinaire :<\/strong><\/div>\n<ul>\n<li>Date : 20 juin 2023<\/li>\n<li>Heure : 15h00 \u2013 16h00 HE<\/li>\n<\/ul>\n<div>Les sujets abord\u00e9s comprennent la conception d&#039;un DCT, la conduite de visites d&#039;essais cliniques \u00e0 distance et les activit\u00e9s li\u00e9es aux essais cliniques dans un DCT, l&#039;utilisation des technologies de sant\u00e9 num\u00e9riques pour acqu\u00e9rir des donn\u00e9es \u00e0 distance dans un DCT, les r\u00f4les et responsabilit\u00e9s du promoteur et des enqu\u00eateurs dans un DCT, etc.<\/div>\n<div><\/div>\n<\/div>\n<ul>\n<li><strong>En savoir plus sur la mani\u00e8re dont le guide DCT RegASK peut vous aider\u00a0:\u00a0<\/strong><strong><a href=\"https:\/\/regask.com\/fr\/regulatory-guidebooks-paved-the-way-for-decentralized-clinical-trials\/\" target=\"_blank\" rel=\"noopener\">Les guides r\u00e9glementaires ont ouvert la voie aux essais cliniques d\u00e9centralis\u00e9s<\/a><\/strong><\/li>\n<li>Besoin d&#039;en savoir plus sur les changements r\u00e9glementaires DCT ? <a href=\"https:\/\/regask.com\/fr\/contact-2\/\" target=\"_blank\" rel=\"noopener\">Contactez les experts de RegASK.<\/a><\/li>\n<\/ul>\n<div><\/div>\n<a href=\"https:\/\/regask.com\/fr\/contact-2\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Contactez RegASK pour plus de d\u00e9tails<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/decentralized-clinical-trials-dct-draft-guidance-06202023\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>En savoir plus<\/span>\n\t<\/a>\n\n<div class=\"row\"  id=\"row-2064080871\">\n\n\t<div id=\"col-950798075\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/regask.com\/fr\/etudes-de-cas\/ressources-etudes-de-cas-dispositifs-medicaux\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Lire les \u00e9tudes de cas sur le secteur des dispositifs m\u00e9dicaux<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>La FDA am\u00e9ricaine a r\u00e9cemment publi\u00e9 le projet de lignes directrices sur les essais cliniques d\u00e9centralis\u00e9s et a \u00e9galement programm\u00e9 un webinaire pour discuter de ce projet de lignes directrices. Le projet de lignes directrices porte sur les essais cliniques d\u00e9centralis\u00e9s pour les m\u00e9dicaments, les produits biologiques et les dispositifs m\u00e9dicaux. Projet de lignes directrices \u00e0 l&#039;intention de l&#039;industrie, des chercheurs et des autres parties prenantes (fda.gov). D\u00e9tails du webinaire : Date : 20 juin 2023 Heure : 15h00\u2026<\/p>","protected":false},"author":39,"featured_media":3995,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39],"tags":[40],"class_list":["post-4274","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-devices-insights","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Webinar: Decentralized Clinical Trials | RegASK<\/title>\n<meta name=\"description\" content=\"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/webinaire-sur-les-essais-cliniques-decentralises-de-la-fda\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA Announces Webinar to Discuss Decentralized Trial Draft Guidance\" \/>\n<meta property=\"og:description\" content=\"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/webinaire-sur-les-essais-cliniques-decentralises-de-la-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-24T05:42:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-16T16:16:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"US FDA Announces Webinar to Discuss Decentralized Trial&hellip;\",\"datePublished\":\"2023-05-24T05:42:52+00:00\",\"dateModified\":\"2024-10-16T16:16:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\"},\"wordCount\":213,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Medical Devices\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\",\"name\":\"FDA Webinar: Decentralized Clinical Trials | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"datePublished\":\"2023-05-24T05:42:52+00:00\",\"dateModified\":\"2024-10-16T16:16:15+00:00\",\"description\":\"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"width\":330,\"height\":300,\"caption\":\"India Proposed Amendment To New Drugs And Clinical Trials Rules\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Webinaire de la FDA : Essais cliniques d\u00e9centralis\u00e9s | RegASK","description":"La FDA am\u00e9ricaine a r\u00e9cemment publi\u00e9 le projet de lignes directrices sur les essais cliniques d\u00e9centralis\u00e9s et a \u00e9galement programm\u00e9 un webinaire pour discuter de ce projet de lignes directrices.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/webinaire-sur-les-essais-cliniques-decentralises-de-la-fda\/","og_locale":"fr_FR","og_type":"article","og_title":"US FDA Announces Webinar to Discuss Decentralized Trial Draft Guidance","og_description":"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.","og_url":"https:\/\/regask.com\/fr\/webinaire-sur-les-essais-cliniques-decentralises-de-la-fda\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2023-05-24T05:42:52+00:00","article_modified_time":"2024-10-16T16:16:15+00:00","og_image":[{"width":330,"height":300,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"US FDA Announces Webinar to Discuss Decentralized Trial&hellip;","datePublished":"2023-05-24T05:42:52+00:00","dateModified":"2024-10-16T16:16:15+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/"},"wordCount":213,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","keywords":["Latest Insights"],"articleSection":["Medical Devices"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/","url":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/","name":"Webinaire de la FDA : Essais cliniques d\u00e9centralis\u00e9s | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","datePublished":"2023-05-24T05:42:52+00:00","dateModified":"2024-10-16T16:16:15+00:00","description":"La FDA am\u00e9ricaine a r\u00e9cemment publi\u00e9 le projet de lignes directrices sur les essais cliniques d\u00e9centralis\u00e9s et a \u00e9galement programm\u00e9 un webinaire pour discuter de ce projet de lignes directrices.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","width":330,"height":300,"caption":"India Proposed Amendment To New Drugs And Clinical Trials Rules"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plateforme d&#039;intelligence artificielle multi-agents pour la veille r\u00e9glementaire et l&#039;orchestration des flux de travail dans le secteur des sciences de la vie et des produits de consommation. RegASK combine des LLM verticaux, une architecture d&#039;IA multi-agents et une communaut\u00e9 mondiale de plus de 1\u00a0800 experts pour fournir une veille r\u00e9glementaire, une analyse d&#039;impact, l&#039;automatisation des processus de conformit\u00e9 et des r\u00e9sultats pr\u00eats pour l&#039;audit dans plus de 160 pays.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Beno\u00eet Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/4274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=4274"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/4274\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/3995"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=4274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=4274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=4274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}